We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

By LabMedica International staff writers
Posted on 18 Apr 2025
Print article
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in forensic investigations and biosensing. Fluorophores have been utilized by scientists to highlight cells and tissues under specialized microscopes, making even the smallest details visible. These molecules also play a crucial role in tracking diseases, studying cellular functions, and assisting in the diagnosis of various health conditions. Now, researchers have developed tiny, clay-based materials known as fluorescent polyionic nanoclays, which can be tailored for numerous applications, including improving medical tests.

These fluorescently labeled nanoclays, created by researchers at the University of Missouri-Columbia (Columbia, MO, USA), exhibit an exceptional brightness of 7,000 brightness units when normalized by volume, marking the highest levels ever recorded for a fluorescent material. This increased brightness makes these materials highly effective for sensitive optical detection methods, leading to stronger analytical signals and improved detection. These enhancements open up new possibilities for advanced sensors and contrast agents in medical imaging. Published in Chemistry of Materials, the study emphasizes the versatility of these nanoclays, which can be adapted to a variety of applications. They have a high degree of functionality, allowing for precise control over the number and type of fluorescent molecules attached to their surfaces. This capability provides a flexible platform where the optical and physicochemical properties of the nanoclays can be finely tuned by selecting and attaching specific molecules.

One of the key features of these nanoclays is their ability to be easily customized, making them suitable for diverse applications in different fields. Initial tests suggest that these materials are safe for medical use, potentially enabling doctors to see inside the body with greater clarity. Although fluorescence remains the primary focus of current research, the team plans to further explore the customization of these nanoclays by incorporating other molecules, such as amino acids, antibodies, DNA aptamers, and ligands for selective metal binding. This opens up opportunities for applications beyond just imaging and sensing. These materials could also play a significant role in drug delivery, improving medical tests, monitoring diseases, and aiding in cancer treatment.

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Total Thyroxine Assay
Total Thyroxine CLIA Kit
New
Cytomegalovirus Test
NovaLisa Cytomegalovirus (CMV) IgG Test

Print article

Channels

Molecular Diagnostics

view channel
Image: Health Canada has approved SPINEstat, a first-in-class diagnostic blood test for axSpA, as a Class II medical device (Photo courtesy of Augurex)

First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis

Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.